Latest Breaking News On - Total xerostomia questionnaire - Page 1 : comparemela.com

Results of a Phase 1, Open-label,Dose-escalation Study of Gene Therapy with AAV2-hAQP1 as Treatment for Grade 2 and 3 Radiation-induced Late Xerostomia and Parotid Gland Hypofunction -.

United statesMichaelt brennanDose escalation studyGene therapyLate xerostomiaParotid gland hypofunctionInduced xerostomiaUnmet medical needStudy designSymptom inventoryChange questionnaireBaseline characteristicsTotal xerostomia questionnaireDry mouthRelatedtreatment emergent adverse eventsXerostomia questionnaire